Niki BioSolutions (NIKI) Revenue (2024)
Niki BioSolutions' Revenue came in at $319,264 for FY2025.
Analysis
Niki BioSolutions (NIKI) Revenue (2024) Analysis & Trends
Going back to FY2017, Niki BioSolutions' Revenue data covers 7 years.
- Revenue carries a three-year compound annual growth rate of -37.3% (FY2022 to FY2025).
- The FY2025 figure represents the lowest annual Revenue since FY2019.
- Per Business Quant, earlier years put Revenue at $1.32 million in FY2024, $431,378 in FY2023 (-66.7%) and $1.3 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Niki BioSolutions | 1.06 Mn | 817,586.43 | - | - |
API Access
Niki BioSolutions Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NIKI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NIKI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NIKI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();